https://scholars.lib.ntu.edu.tw/handle/123456789/551095
標題: | Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients | 作者: | TUNG-HUNG SU JIA-HORNG KAO |
公開日期: | 2017 | 出版社: | Blackwell Publishing Ltd | 卷: | 37 | 期: | 2 | 起(迄)頁: | 310-311 | 來源出版物: | Liver International | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009070606&doi=10.1111%2fliv.13315&partnerID=40&md5=57970671fae962f592d49280a495f9bc https://scholars.lib.ntu.edu.tw/handle/123456789/551095 |
ISSN: | 1478-3223 | DOI: | 10.1111/liv.13315 | SDG/關鍵字: | entecavir; antivirus agent; entecavir; guanine; virus DNA; acute hepatitis A; antiviral therapy; cancer risk; Child Pugh score; chronic hepatitis B; decompensated liver cirrhosis; drug response; hepatitis E; human; incidence; Letter; liver cell carcinoma; liver cirrhosis; mortality; public health service; risk reduction; superinfection; survival; Taiwan; analogs and derivatives; chronic hepatitis B; genetics; Hepatitis B virus; liver cell carcinoma; liver cirrhosis; liver tumor; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。